Blog
RSS FeedPosted by Michael Wonder on 13 Jun 2017
Cannabis rules loosened after Senate gangs up on government
13 June 2017 - Terminally ill patients will get faster access to medicinal marijuana and be able to import their ...
Posted by Michael Wonder on 13 Jun 2017
Patients at risk as hospitals report shortages of ‘1500 life saving medicines
13 June 2017 - Australia's hospitals are running out of life-saving medicines including antibiotics and chemotherapies with more than 1500 ...
Posted by Michael Wonder on 13 Jun 2017
Generic and biosimilar prescription medicines, 2016
13 June 2017 -The generic and biosimilar prescription medicines: TGA annual summary 2016 publication provides details of all generic and ...
Posted by Michael Wonder on 05 Jun 2017
Prima’s trial backs safety of metastatic breast cancer drug
5 June 2017 - The Lucy Turnbull-chaired biotech Prima Biomed has revealed new data that backs the safety of its ...
Posted by Michael Wonder on 31 May 2017
South Australia slashes pathology, medical science jobs
31 May 2017 - Medical unions say timely patient treatments and diagnoses could be at risk after the South Australian ...
Posted by Michael Wonder on 26 May 2017
Investing $5.9 million to tackle antimicrobial resistance
26 May 2017 - The Australian Government will invest $5.9 million from the Medical Research Future Fund to help tackle the ...
Posted by Michael Wonder on 25 May 2017
Medical research reforms to improve our future health
25 May 2017 - The Australian Government provides more than $800 million through the National Health and Medical Research Council each ...
Posted by Michael Wonder on 25 May 2017
Strength in clinical trials set to grow with funding boost
25 May 2017 - Australia’s world-class clinical trial capabilities are set to grow, with a $33 million funding boost announced ...
Posted by Michael Wonder on 10 May 2017
MTPConnect welcomes 2017 Budget: investment in MTP research translation and commercialisation
10 May 2017 - MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has ...
Posted by Michael Wonder on 02 May 2017
MSD plans 2017 launch of Renflexis (infliximab) in Australia
1 May 2017 - Latest MSD biosimilar secures TGA approval. ...
Posted by Michael Wonder on 02 May 2017
Survey shows biotech industry buoyant, but fearing imminent policy change
2 May 2017 - AusBiotech’s annual survey of biotechnology industry CEOs shows the strongest year on record, but the result ...
Posted by Michael Wonder on 01 May 2017
Reform of the Orphan Drug Program - transition arrangements
1 May 2017 - The Orphan Drug Program provides an incentive for sponsors to bring medicines for a small population to ...
Posted by Michael Wonder on 26 Apr 2017
Changes to pharmaceutical extension of term application procedures the latest front in the battle for savings in Australia’s health care budget
26 April 2017 - It’s no secret that the Australian Government is struggling to manage the cost of its health ...
Posted by Michael Wonder on 20 Apr 2017
Therapeutic Goods Administration approves Afstyla - CSL Behring's novel recombinant haemophilia A treatment
19 April 2017 - In clinical trials, patients undergoing prophylaxis with Afstyla experienced a median annualised spontaneous bleeding rate of ...
Posted by Michael Wonder on 18 Apr 2017
Peak bodies unite against threat to commercialisation of Australian medical research
18 April 2017 - AusBiotech has joined fellow organisations - Research Australia, Medicines Australia, Medical Technologies Association of Australia and ...